Three-year durability of dual-nucleoside versus triple-nucleoside therapy in a Thai population with HIV infection. [electronic resource]
Producer: 20050831Description: 693-701 p. digitalISSN:- 1525-4135
- Adult
- Anti-HIV Agents -- administration & dosage
- Antiretroviral Therapy, Highly Active -- adverse effects
- CD4 Lymphocyte Count
- Didanosine -- administration & dosage
- Dideoxynucleosides -- administration & dosage
- Female
- HIV Infections -- drug therapy
- HIV-1 -- drug effects
- Humans
- Lamivudine -- administration & dosage
- Male
- RNA, Viral -- blood
- Retrospective Studies
- Stavudine -- administration & dosage
- Thailand
- Time Factors
- Zidovudine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.